Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Genprex Inc (NASDAQ: GNPX)

 
GNPX Technical Analysis
5
As on 23rd Oct 2025 GNPX SHARE Price closed @ 9.16 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.15 & Strong Buy for SHORT-TERM with Stoploss of 2.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GNPXSHARE Price

Open 11.34 Change Price %
High 11.34 1 Day -1.80 -16.42
Low 7.71 1 Week 8.91 3564.00
Close 9.16 1 Month 8.90 3423.08
Volume 5628248 1 Year 6.68 269.35
52 Week High 11.50 | 52 Week Low 0.14
 
NASDAQ USA Most Active Stocks
BYND 2.84 -20.67%
AMRS 0.14 100.00%
WBA 11.98 0.50%
TSLA 448.98 2.28%
LMDX 0.02 0.00%
INTC 38.16 3.36%
VTYX 6.60 70.98%
NVDA 182.16 1.04%
AKTS 0.04 0.00%
ADAP 0.07 0.00%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
EGRX 1.00 900.00%
CTXRW 0.14 600.00%
ORGS 0.90 260.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
 
NASDAQ USA Top Losers Stocks
COMSP 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
OPI 0.06 -70.00%
OPI 0.06 -70.00%
AXAS 0.03 -70.00%
 
 
GNPX
Daily Charts		 GNPX
Intraday Charts		 Whats New @
Bazaartrend		 GNPX
Free Analysis
 
GNPX Important Levels Intraday
RESISTANCE16.16
RESISTANCE13.91
RESISTANCE12.53
RESISTANCE11.14
SUPPORT7.18
SUPPORT5.79
SUPPORT4.41
SUPPORT2.16
 
GNPX Forecast October 2025
Share
4th UP Forecast10.93
3rd UP Forecast10.36
2nd UP Forecast10.01
1st UP Forecast9.66
1st DOWN Forecast8.66
2nd DOWN Forecast8.31
3rd DOWN Forecast7.96
4th DOWN Forecast7.39
 
GNPX Weekly Forecast
4th UP Forecast10.18
3rd UP Forecast9.85
2nd UP Forecast9.65
1st UP Forecast9.45
1st DOWN Forecast8.87
2nd DOWN Forecast8.67
3rd DOWN Forecast8.47
4th DOWN Forecast8.14
 
GNPX Forecast2025
4th UP Forecast33.88
3rd UP Forecast25.95
2nd UP Forecast21.05
1st UP Forecast16.15
1st DOWN Forecast2.17
2nd DOWN Forecast-2.73
3rd DOWN Forecast-7.63
4th DOWN Forecast-15.56
 
 
GNPX Other Details
Segment EQ
Market Capital 109789448.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
GNPX Address
GNPX
 
GNPX Latest News
 
Your Comments and Response on Genprex Inc
 
GNPX Business Profile
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes who currently have limited treatment options. The company works with institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Its lead product candidate is REQORSA (GPX-001), which is in preclinical stage for the treatment of non-small cell lung cancer (NSCLC). It is also developing GPX-002, a preclinical stage gene therapy for diabetes. The company also offers ONCOPREX, a nanoparticle delivery system. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Address: 3300 Bee Cave Road, Austin, TX, United States, 78746
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service